Started vraylar low dose

Medications
1

1.5 a day for 2 weeks to see how i respond

5 Likes
2

Welcome to the club @HuckFinn

I hope that it works out for the both of us.

Will you be updating us on how you are doing with it?

1.5mg will be my dose - I dont think that I could tolerate higher doses - it is kind of activating for me.

1.5mg is actually a therapeutic dose for schizophrenia - 3mg is the lowest target dose for bipolar

1 Like
3

yeah ill say how it resolves as it comes along :slight_smile:

1 Like
4

It’s similar to Rexulti which is what I am on, but Rexulti is a modulator of the same receptors instead of an agonist, strictly speaking- it balances levels of D2 instead of always increasing them

But if you struggle with negative symptoms, Vraylar is a safer bet

2 Likes
5

what do you mean by “Activating”?

6

I mean stimulating

1 Like
7

Would u say that rexulti or vraylar is more closley related to abilify in their mechanism of action

1 Like
8

My doc described vraylar as an abilify type

9

Nice @shutterbug lol. The king and the duke reference :slight_smile: good one

10

plz upate…???

1 Like
11

I just started today. I’ll be keeping up

1 Like
12

O.k man…!!!..

1 Like
13

Are you considering a new med @far_cry0 ? So far i find this med calming

2 Likes
14

let’s see…!!!

1 Like
15

Vraylar is. It is straight up activating while Rexuti is “modulating”, meaning Vraylar is going to make you more active while Rexulti MAY make you more active. Rexulti detects if you need more or less, Vraylar just gives you more (dopamine, they handle dopamine primarily).

2 Likes
16

This is what Vraylar (Cariprazine) basically does :

While the drug shares commonalities with many already-approved atypical antipsychotics, it also has several mechanistic differences. Like other antipsychotics, it modulates the neurotransmission of dopamine at various receptors (e.g. D2 receptors) to prevent positive symptoms of schizophrenia and manic symptoms of bipolar disorder. Unlike many older antipsychotics, it acts primarily upon D3 receptors and is capable of ameliorating negative symptoms of schizophrenia when dopamine levels plummet.

2 Likes
17

I’m keeping Vraylar on my radar, it might be my next med. (when it comes to Europe). I’m definitely watching how @Wave and yourself get on with it.

4 Likes